29,650 Followers on Owler
OverviewCompetitorsAcquisitionsInvestmentsNews & Insights

Novartis Competitors or Alternatives

Novartis's top competitors include Pfizer, AstraZeneca and Merck.

Unlock 15 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Novartis's company profile

Vasant Narasimhan

CEO

74/100
75,883
$0
$50.3B
  • $0
    $50.3B
  • 75,883
    $0
  • $50.3B
  • 74/100
  • 75,883
  • $0
  • $50.3B
View ProfileView
1
Novartis's Competitor - Pfizer logo

Albert Bourla

Chairman & CEO

69/100
83,000
$1B
$63.6B
  • $1B
    $63.6B
  • 83,000
    $1B
  • $63.6B
  • 69/100
  • 83,000
  • $1B
  • $63.6B
View ProfileView
2
Novartis's Competitor - AstraZeneca logo

Pascal Soriot

CEO

72/100
89,900
$100M
$51.2B
  • $100M
    $51.2B
  • 89,900
    $100M
  • $51.2B
  • 72/100
  • 89,900
  • $100M
  • $51.2B
View ProfileView
3
Novartis's Competitor - Merck logo

Robert M. Davis

Chairman & CEO

78/100
69,000
$8B
$64.2B
  • $8B
    $64.2B
  • 69,000
    $8B
  • $64.2B
  • 78/100
  • 69,000
  • $8B
  • $64.2B
View ProfileView
4
Novartis's Competitor - Amgen logo

Robert A. Bradway

Chairman & CEO

51/100
25,200
$4.1B
$33.4B
  • $4.1B
    $33.4B
  • 25,200
    $4.1B
  • $33.4B
  • 51/100
  • 25,200
  • $4.1B
  • $33.4B
View ProfileView
5
Novartis's Competitor - Bristol-Myers Squibb logo

Christopher Boerner

CEO

44/100
34,300
$23.5B
$48.3B
  • $23.5B
    $48.3B
  • 34,300
    $23.5B
  • $48.3B
  • 44/100
  • 34,300
  • $23.5B
  • $48.3B
View ProfileView
Novartis' top 18 competitors are Pfizer, AstraZeneca, Merck, Gilead, Amgen, Bristol-Myers Squibb, Johnson & Johnson, GSK, Cipla, Abbott, Roche, Lilly, TEVA, Bayer , Boston Scientific, Medtronic, Illumina and P&G. Together they have raised over 75.6B between their estimated 1.2M employees. Novartis has 75,883 employees and is ranked 9th among it's top 10 competitors. The top 10 competitors average 68,650.

Novartis VS Pfizer

Pfizer is the top competitor of Novartis. Pfizer is a Public company that was founded in New York, New York in 1849. Like Novartis, Pfizer also operates in the Pharmaceuticals sector. Pfizer has 7,117 more employees vs. Novartis.

Novartis VS AstraZeneca

AstraZeneca is seen as one of Novartis's biggest rivals. AstraZeneca was founded in Cambridge, England} in 1999. Like Novartis, AstraZeneca also competes in the Pharmaceuticals space. Compared to Novartis, AstraZeneca generates $889M more revenue.

Novartis VS Merck

Merck is perceived as one of Novartis's biggest rivals. Merck was founded in 1891, and is headquartered in Rahway, New Jersey. Like Novartis, Merck also operates in the Pharmaceuticals space. Merck generates $13.9B more revenue vs. Novartis.

Looking for similar companies to Novartis?

Similar Companies

Pharmaceuticals & Biotechnology companies with revenue in $50-100B range

See 11 companies 
Companies in Switzerland with employees in 50-100K range

See 16 companies 
Pharmaceuticals & Biotechnology companies in Basel-City

See 55 companies 
Pharmaceuticals companies with revenue in $50-100B range

See 11 companies 
Pharmaceuticals & Biotechnology companies with employees in 50-100K range

See 20 companies 
Pharmaceuticals companies in Basel-City

See 24 companies 
Pharmaceuticals companies in Basel

See 33 companies 
Pharmaceuticals companies with employees in 50-100K range

See 15 companies 
Companies in Europe with revenue in $50-100B range

See 67 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Novartis and Novartis's Competitors

March 28, 2025Pharmabiz
Novartis will present data from studies across its neuroscience portfolio, including seven─year disability outcomes and safety data from the ALITHIOS o...
March 27, 2025Pharmabiz
Merck, known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma), a global pharmaceutical co...
March 28, 2025Pharmabiz
GSK plc, announced that the US FDA has approved Blujepa (gepotidacin) for the treatment of female adults (=40 kg) and paediatric patients (=12 years, =...

Frequently Asked Questions about Novartis

  1. Who are Novartis's top competitors?

    Novartis's top 3 competitors are Pfizer, AstraZeneca, Merck.

  2. Who is similar to Novartis?

    Pfizer is the most similar to Novartis. AstraZeneca and Merck are also similar to Novartis.

  1. Are Novartis and Pfizer competitors?

    Yes, Pfizer is one of Novartis’s top competitors.